Eli Lilly to spend another $5.3B on production site for Mounjaro, Zepbound

Eli Lilly chases $100bn weight loss market with $5.3bn US investment

US drugmaker races to scale up ingredient production to meet demand for Mounjaro and Zepbound jabs